Elastography imaging market projected to reach $64.1 billion by 2030

The elastography imaging market is projected to grow from $3.87 billion in 2025 to $64.1 billion by 2030, representing a compound annual growth rate (CAGR) of approximately 10.7% between 2026 and 2030. This non-invasive diagnostic technology measures the stiffness of organs and tissues using low-frequency vibrations, supporting clinical fields such as radiology, cardiology, obstetrics, and urology.

Key growth drivers include the rising prevalence of liver and musculoskeletal diseases, the expansion of diagnostic imaging services, and increased clinical awareness of tissue stiffness assessment. The adoption of AI-assisted image analysis and the demand for early disease diagnosis in oncology and cardiology are also expected to fuel market expansion.

In recent developments, Shenzhen-based Mindray Biomedical Electronics launched the Resona A20, a premium ultrasound system featuring AI-driven tools for breast and liver assessment. Additionally, Mindray North America partnered with Eagle Medical Solutions to integrate advanced medical imaging solutions to enhance patient monitoring and diagnostic capabilities.